Key Finding
TEAS treatment significantly increased both implantation rate and clinical pregnancy rate in women with recurrent IVF implantation failure compared to their previous standard IVF cycles.
Women who have experienced repeated IVF failures despite having good quality embryos may benefit from a noninvasive electrical stimulation technique applied to acupuncture points. Researchers in Taiwan studied 25 women who had previously been unable to get pregnant after multiple IVF cycles, even when high-quality embryos were transferred. These patients received transcutaneous electrical acupoint stimulation (TEAS) before and during their next IVF cycle—a technique that delivers gentle electrical currents through the skin at specific acupuncture points without using needles. The results showed significant improvements when TEAS was added to standard IVF treatment. Both the implantation rate (how often embryos successfully attach to the uterus) and clinical pregnancy rate increased meaningfully compared to the same patients' previous IVF attempts without TEAS. This is particularly encouraging for patients who have faced the disappointment of repeated implantation failures. TEAS offers a promising complementary approach because it's noninvasive, relatively easy to administer, and can be performed with limited training. The study suggests that for women struggling with recurrent implantation failure, adding TEAS treatment to their IVF protocol might improve their chances of achieving pregnancy. While more research is needed to refine the protocol and confirm these findings in larger studies, this technique represents a hopeful option for patients in difficult IVF situations. If you're considering TEAS as part of your fertility treatment, consult with a qualified acupuncturist who has experience working with fertility patients and IVF protocols.
This retrospective study evaluated transcutaneous electrical acupoint stimulation (TEAS) efficacy in 25 women with repeated implantation failure following IVF-embryo transfer. Patients served as their own controls, comparing IVF cycles with TEAS treatment to their previous cycles receiving only standard IVF protocols. Low-frequency TEAS was administered noninvasively prior to and during the IVF-ET cycle. Results demonstrated statistically significant improvements in both implantation rate and clinical pregnancy rate in TEAS-supplemented cycles compared to standard treatment alone in this cohort. Biochemical pregnancy rates were also assessed. The study population consisted exclusively of patients who had failed to conceive after multiple IVF cycles despite transfer of good-quality embryos. Clinical takeaway: TEAS represents a promising adjunctive therapy for patients with recurrent implantation failure, offering a noninvasive, reproducible intervention that may enhance IVF-ET outcomes in this challenging patient population. The technique's accessibility and ease of implementation make it suitable for broader clinical application, though larger prospective trials are warranted.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Three distinct BNC1 gene variants contribute to premature ovarian insufficiency through different molecular mechanisms, with each variant affecting separate biological pathways including immune regulation, antiviral responses, and reproductive development.
📌 LbGP supplementation significantly improved oocyte quality in aged mice by restoring mitochondrial function through PPAR signaling activation and remodeling the ovarian microenvironment by reducing inflammation and increasing functional granulosa cells.
📌 Copper deficiency during pregnancy causes fetal growth restriction by disrupting placental structure, impairing trophoblast cell function, and dysregulating lipid metabolism in the placenta.